Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet K Dale

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.
Blood|October 25, 2003
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturationHarutaka Katano, Mir A Ali, Andriani C Patera, et al.
The American Journal of Surgical Pathology|June 17, 2005
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndromeIrina Maric, Stefania Pittaluga, Janet K Dale, et al.
Clinical Biochemistry|February 7, 2012
Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytesRaffick A R Bowen, Kennichi C Dowdell, Janet K Dale, et al.
American Journal of Hematology|August 4, 2007
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromeV Koneti Rao, Kennichi C Dowdell, Janet K Dale, et al.
BMC Medical Genetics|July 4, 2007
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbLilia L Bi, George Pan, T Prescott Atkinson, et al.
Human Genetics|February 1, 2006
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndromeShigui Zhu, Amy P Hsu, Marla M Vacek, et al.
American Journal of Hematology|January 25, 2006
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, et al.
Pediatric Blood & Cancer|February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Susan Price, Katie Perkins, et al.
Nature|September 28, 2002
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiencyHyung J Chun, Lixin Zheng, Manzoor Ahmad, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.
Blood|October 25, 2003
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturationHarutaka Katano, Mir A Ali, Andriani C Patera, et al.
The American Journal of Surgical Pathology|June 17, 2005
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndromeIrina Maric, Stefania Pittaluga, Janet K Dale, et al.
Clinical Biochemistry|February 7, 2012
Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytesRaffick A R Bowen, Kennichi C Dowdell, Janet K Dale, et al.
American Journal of Hematology|August 4, 2007
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromeV Koneti Rao, Kennichi C Dowdell, Janet K Dale, et al.
BMC Medical Genetics|July 4, 2007
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbLilia L Bi, George Pan, T Prescott Atkinson, et al.
Human Genetics|February 1, 2006
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndromeShigui Zhu, Amy P Hsu, Marla M Vacek, et al.
American Journal of Hematology|January 25, 2006
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, et al.
Pediatric Blood & Cancer|February 14, 2009
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Susan Price, Katie Perkins, et al.
Nature|September 28, 2002
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiencyHyung J Chun, Lixin Zheng, Manzoor Ahmad, et al.
Pageof 3